Regulatory and Standard Setting Organizations

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-15-2019
Volume 2019 eBook
Issue 3
Pages: 38-40

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

 

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

 

Read this article in Pharmaceutical Technology’s December 2019 Regulatory Sourcebook.

Articles in this issue
PTebook1219_PharmacopeiaCompendia_PT6_RevisionProcess.jpg
Revision Process for Global/National Pharmacopoeias (eBook)
PTebook1219_Resources_Organizations.jpg
Regulatory and Standard Setting Organizations
PTebook1219_Resources_Guidelines.jpg
Resources, Guidelines, and Guidance Documents
PTebook1219_Quality_DOE_Shanley.jpg
Design of Experiments Gains Ground in Biopharma Development
PTebook1219_RegulatoryUpdate_Peters.jpg
Warning Letters Signal Steps to Compliance
PTebook1219_QRM_Plans_ATE_Schniepp.jpg
Quality Risk Management Plans Create Effective Quality Systems
PTebook1219_Compliance_Quality_Shanley.jpg
Moving from Compliance to Quality
PTebook1219_PharmacopeiaCompendia_PT7_SurveillanceProcess.jpg
Surveillance Process for Industry: Monitoring Pharmacopoeia Revisions (eBook)

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Moves to Secure Supply of Critical Drugs Used During Pregnancy

Susan Haigney
July 10th 2025
Article

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Document Review and Quality Control Concept. Document with a checkmark, quality assurance, and process control. auditing, compliance, verification, data inspection, and business workflow management. | Image Credit: © Supatman - stock.adobe.com

A Novel, Enhanced, and Sustainable Approach to Audit Trail Review

Diana Russo
July 4th 2025
Article

Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney
June 25th 2025
Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Six Biosimilars Part of EMA’s Authorization Recommendations in June

Susan Haigney
June 23rd 2025
Article

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.